Persium Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$919K Buy
10,728
+181
+2% +$17.7K 0.48% 39
2026
Q2
$1.09M Buy
10,547
+1,033
+11% +$92.2K 0.71% 20
2026
Q1
$683K Buy
9,514
+493
+5% +$38K 0.54% 44
2025
Q4
$716K Sell
9,021
-550
-6% -$43.4K 0.52% 36
2025
Q3
$722K Buy
9,571
+561
+6% +$38.4K 0.54% 36
2025
Q2
$622K Buy
9,010
+785
+10% +$51.5K 0.51% 37
2025
Q1
$557K Buy
8,225
+1,035
+14% +$61.9K 0.53% 35
2024
Q4
$323K Buy
+7,190
New +$403K 0.32% 48

Other funds holding CVS

Persium Advisors's CVS Position: Q3 2026 in Review

Persium Advisors increased its CVS Health (CVS) stake by 1.7% in Q3 2026, buying an estimated $17.7K and bringing the position to 10,728 shares worth $919K. The position accounts for 0.48% of the portfolio, ranked #39.

Persium Advisors first reported a position in CVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.09M in Q2 2026. 456 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Persium Advisors held 10,728 shares of CVS Health worth $919K as of Q3 2026.
  • Persium Advisors bought 181 CVS Health shares in Q3 2026, an estimated $17.7K.
  • CVS Health made up 0.48% of Persium Advisors's portfolio in Q3 2026, its #39 holding.
  • Persium Advisors first reported a position in CVS Health in Q4 2024 and has held it in 8 quarters since.
  • Persium Advisors's CVS Health position peaked at $1.09M in Q2 2026.
  • 456 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Persium Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.